For decades, we've been told “Lower LDL is Better.” But what if, in our myopic obsession with LDL and ApoB, we’ve missed a more important signal? Time to reframe the ...
The “dose-response” relationships that apolipoprotein B (apoB) and LDL cholesterol have with coronary artery disease, all-cause mortality, and cardiovascular mortality do not appear to have lower ...
Lowest Price Guarantee allows you to get a lower price on an identical item when you present any online or local competitor’s ad.
You’ve likely heard plenty about LDL (“bad”) and HDL (“good”) cholesterol. But there’s another heart-health marker worth knowing: ApoB. This lesser-known blood test can offer a more accurate picture ...
ApoB testing outperforms traditional cholesterol measures in preventing heart attacks and strokes while remaining cost-effective. It more accurately identifies risk, leading to better treatment ...
Healio: Evinacumab safe, shows durable long-term LDL lowering in children with HoFH
Please provide your email address to receive an email when new articles are posted on . Evinacumab durably lowered LDL out to 72 weeks in young patients with genetic high cholesterol. The treatment ...
TCTMD: Even Low Levels of ApoB and LDL Linked With CAD, Mortality: UK Biobank
Even Low Levels of ApoB and LDL Linked With CAD, Mortality: UK Biobank
Renal & Urology News: ApoB May Be Better Biomarker for CVD Events
(HealthDay News) — Clinical benefit of reduced low-density lipoprotein cholesterol (LDL-C) levels may depend on the corresponding reduction in apolipoprotein B (apoB)-containing lipoprotein particles, ...
American Council on Science and Health: Better Tests, Longer Lives, Higher Costs? The ApoB Dilemma